SEC Form 3 · accession 0001209191-17-005639
ANAPTYSBIO, INC · ANAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
Kevin J Kinsella
10% Owner
Avalon Ventures VII L P
10% Owner
Stephen Lawrence Tomlin
10% Owner
Period of report
Jan 25, 2017
Accepted (ET)
Jan 25, 2017 · 9:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001370053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 2,036,932 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common Stock (right to buy)F1,F2 | $4.55 | holding | — | — | — | — | Nov 4, 2018 | Common Stock | 117,483 | — | D |
Explanation of responses
- F1The general partner of Avalon Ventures VII, L.P. is Avalon Ventures VII GP, LLC. The managing members of Avalon Ventures VII GP, LLC are Kevin J. Kinsella and Stephen L. Tomlin.
- F2This warrant is exercisable at any time.